基于基因型耐药性检测的经验对比定制疗法用于杆菌根除:系统性审查和元分析
Meng Li1, Xiaolei Wang1, Wenting Meng1
1Department of Gastroenterology, Peking University First Hospital, Beijing, China.
Therapeutic advances in gastroenterology
|September 5, 2023
概括
基因型耐药性引导的量身定制疗法显示出消除Helicobacter pylori感染的前景,特别是与经验三重疗法相比. 然而,它的优越性比经验四重疗法需要进一步的研究.
科学领域:
- 胃肠病学和传染病学
- 分子诊断和治疗学分子诊断和治疗学
背景情况:
- 由于抗菌素耐药性增加,实证疗法对Helicobacter pylori (H. pylori) 根除的疗效下降.
- 目前的指导方针建议基因型耐药导向治疗,但其有效性的临床证据有限.
研究的目的:
- 以基因型耐药性测试为指导的量身定制治疗的疗效与H. pylori感染的标准实证治疗进行比较.
主要方法:
- 随机对照试验 (RCT) 的系统审查和元分析.
- 搜索了PubMed,Embase和Cochrane图书馆的相关研究.
- 主要结局:H. pylori根除率;次要结局:不良事件 (AE). 使用随机效应模型进行分析.
主要成果:
- 包括12个与3940名患者参与的RCT. 量身定制的治疗比实证疗法显示出更高的根除率,尽管并不总是统计学上显著.
- 三重治疗:量身定制的方法显著改善了根除率 (ITT和PP分析,p < 0.0001).
- 四重治疗:经验方法显示更高的根除率 (p=0.001对于BQT,p=0.009对于非BQT). 量身定制和经验组之间的AE没有显著差异 (p=0.17).
结论:
- 基于基因型耐药性的量身定制疗法可能比实证三重疗法在H. pylori根除方面更有效.
- 量身定制治疗对实证四重疗法的优越性尚未确立.
- 进一步的大规模,个性化的RCT是指导临床实践所必需的.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
449
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
449
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
155
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
155
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pulmonary Tuberculosis V
200
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
200
Gastritis III: Clinical Manifestations and Management
319
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
319


